Marshall Wace’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$147K Buy
1,700
+900
+113% +$74.9K ﹤0.01% 2887
2026
Q2
$53.9K Sell
800
-900
-53% -$60K ﹤0.01% 2987
2026
Q1
$107K Buy
1,700
+700
+70% +$48.7K ﹤0.01% 2888
2025
Q4
$66.4K Buy
+1,000
New +$64.6K ﹤0.01% 2753

Other funds holding DXCM

Marshall Wace's DXCM Position: Q3 2026 in Review

Marshall Wace held its DexCom (DXCM) position steady in Q3 2026 at 532,804 shares worth $46M. The position accounts for 0.04% of the portfolio, ranked #365.

Marshall Wace first reported a position in DXCM in Q4 2014 and has held it in 29 quarters since. The position peaked at $343M in Q1 2023. 1,054 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Marshall Wace held 532,804 shares of DexCom worth $46M as of Q3 2026.
  • Marshall Wace left its DexCom share count unchanged in Q3 2026.
  • DexCom made up 0.04% of Marshall Wace's portfolio in Q3 2026, its #365 holding.
  • Marshall Wace first reported a position in DexCom in Q4 2014 and has held it in 29 quarters since.
  • Marshall Wace's DexCom position peaked at $343M in Q1 2023.
  • 1,054 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.